Poxel
Latest round
- Series A
Last raised
- Sep 2014
Total raised
- $25M
Investors
- 4
About Poxel
Founded in 2009, Poxel SA operates out of Lyon, France, focusing on the development of treatments for chronic metabolic diseases.690 mn.Poxel SA specializes in the development of innovative biopharmaceutical products targeting chronic diseases with metabolic components. The company's primary offerings include PXL065, a deuterium-stabilized R-pioglitazone designed for non-alcoholic steatohepatitis (NASH); PXL770, an adenosine monophosphate-activated protein kinase (AMPK) activator aimed at rare metabolic diseases; and TWYMEEG® (Imeglimin), approved in 2021 for the treatment of type 2 diabetes in Japan.4. The company is focused on expanding its product line and entering new markets as its therapies progress through clinical trials, particularly in regions with significant unmet needs for metabolic disease treatments.
Who invested in Poxel
4 investors across 3 rounds
See all investors in Poxel
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Poxel
Who invested in Poxel?
Poxel has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Poxel raised?
Poxel has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Poxel last raise money?
Poxel's most recent round on record is a Series A, in Sep 2014.
What does Poxel do?
Founded in 2009, Poxel SA operates out of Lyon, France, focusing on the development of treatments for chronic metabolic diseases.
Where is Poxel headquartered?
Poxel is headquartered in Lyon, France.
Which VCs invest in companies like Poxel?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Poxel's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Poxel? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.